WO2016160796A1 - Keratin treatments - Google Patents
Keratin treatments Download PDFInfo
- Publication number
- WO2016160796A1 WO2016160796A1 PCT/US2016/024698 US2016024698W WO2016160796A1 WO 2016160796 A1 WO2016160796 A1 WO 2016160796A1 US 2016024698 W US2016024698 W US 2016024698W WO 2016160796 A1 WO2016160796 A1 WO 2016160796A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- keratin
- dendrimer
- peptide
- restorative composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/544—Dendrimers, Hyperbranched polymers
Definitions
- present disclosure relates generally to keratin treatments. More particularly, but not by way of limitation, present disclosure relates to skin, nail, hair, and eyelash treatments comprising a keratin-peptide/dendrimer composition for ameliorating a condition of the skin, nail, hair or eyelash.
- Keratin is a term used to describe various structural proteins found in parts of living animals, particularly in mammals and humans.
- keratin is present in the outer layers of the skin and is a major component of hair, including eyelashes, and nails, including fingernails and toenails.
- keratin is a major component of horns, claws, hooves, shells, feathers, and beaks,
- Keratin restorative compositions of the invention include a keratin-peptide and a dendrimer,
- the weight ratio of keratin-peptide to dendrimer can be from about 4: 1 to about 1 ;60,
- the keratin-peptide can include a partially-hydrolyzed keratin.
- the dendrimer can include one or more functional groups that can associate, interact, or react with one or more functional groups on the keratin-peptide.
- the one or more functional groups on the dendrimer may be selected from OH, NH 2 , SH, C0 2 H or others.
- the keratin-peptide and the dendrimer can be associated by the formation of a covalent, ionic or hydrogen bond or through other
- the keratin- eptide remains at least partially exposed for interaction or reaction with keratin of a keratinaceous substrate and the dendrimer functional group extends unidirectionally from the keratin-peptide constituent.
- Exemplary schematic formulas for the keratin-peptide/dendrimer composition and dendrimer are shown in Figure 1 and Figure 2, respectively.
- Dendrimers used in the keratin restorative composition of the invention can include at least one hydrophobic group.
- the hydrophobic group can include, for example, a C6-C20 linear or branched hydrocarbon chain, optionally substituted by one or more functional groups.
- Keratin restorative compositions according to the invention can further include a solvent.
- Additional components in the keratin restorative composition can include one or more of a film forming polymer, a reactive (me1h)acrylate, an epoxidized esterified plant oil, a polyhedral oligomeric silsesquioxane, and' colorant,
- the film forming polymer can be, for example, a cellulose ester, nitrocellulose, or a cellulose acetate alkylate.
- the invention includes a method for ameliorating a condition of a keratinaceous substrate by applying to the keratinaceous substrate a keratin restorative composition of the invention,
- the keratinaceous substrate can be skin, nails and hair,
- Conditions to be ameliorated can be nail delamination, brittleness, cracking, chipping, splitting, dryness, and texturing.
- Keratin restorative compositions of the invention can be made by combining a keratin-peptide and a dendrimer, Combining can include chemically reacting by forming a covalent, ionic, or hydrogen bond. Combining can also include mixing of the keratin-peptide and the dendrimer, The bond between the keratin- eptide and the dendrimer can be formed by the association of the reactive functional groups of the keratin-peptide and the dendrimer,
- FIG. 1 is a schematic structure of a keratin-peptide/dendrimer composition useful in compositions according to the invention.
- FIG. 2 is a schematic representation of a dendrimer unit useful in preparing compositions of the present invention.
- Hydrolyzed keratin has been used as a cosmetic treatment for keratinaceous materials such as skin.
- One of the drawbacks of the use of hydrolyzed keratin is its water solubility.
- the present invention is directed to treatment compositions and restorative compositions that overcome this and other drawbacks associated with the use of existing hydrolyzed keratin treatments.
- the present invention provides a treatment composition or formulation, methods of making the treatment composition or formulation, and methods of using the treatment composition or formulation,
- treatment means of making the treatment composition or formulation, and methods of using the treatment composition or formulation.
- compositions and formulations applied to keratinaceous substrates to prevent, treat, or ameliorate delamination, dryness, brittleness, cracking, chipping, splitting and other natural degradation of keratin material or the keratinaceous substrate.
- the composition and formulation can also be applied to a keratinaceous substrate to improve or enhance the appearance, attractiveness or texture,
- Treatment compositions according to the invention include a combination of a keratin-peptide and a dendrimer.
- the keratin-peptide and dendrimer can be combined to form a keratin-peptide/dendrimer composition in which the keratin-peptide and the dendrimer are associated, as described further below,
- the keratin-peptide/dendrimer composition can include a keratin-peptide with a dendrimer unit attached thereto,
- Keratin-peptide refers to a keratin, a peptide derived from a keratin, a peptide that is structurally similar to keratin or structurally similar to a peptide derived from keratin.
- keratin-peptide can refer to a peptide having a high cystine content
- An exemplary keratin-peptide is hydrolyzed keratin.
- cystines present in the keratin-peptide are in an S- sulphonated form
- a non-limiting, suitable keratin-peptide is commercially-available as ProSinaTM (Keratec Ltd,, Canterbury, NZ), which is described as a purified protein faction isolated from wool which leaves the natural cystine content of the keratin in an active, S-sulpho, form,
- the present invention provides a composition having a dendrimer and a keratin-peptide for bonding to or coating a keratinaceous substrate to prevent or restore delamination, dryness, brittleness, breaking or cracking, ridges, splitting, and texturing or other degradations or imperfections in the keratinaceous substrate,
- a dendrimer and a keratin-peptide for bonding to or coating a keratinaceous substrate to prevent or restore delamination, dryness, brittleness, breaking or cracking, ridges, splitting, and texturing or other degradations or imperfections in the keratinaceous substrate,
- a dendrimer and a keratin-peptide for bonding to or coating a keratinaceous substrate to prevent or restore delamination, dryness, brittleness, breaking or cracking, ridges, splitting, and texturing or other degradations or imperfections in the keratinaceous substrate
- keratinaceous substrate is a material containing or composed of keratin.
- keratinaceous substrates include, for example, skin, hair , (including eyelashes), and nails (including toenails and fingernails).
- the keratin-peptide includes a plurality of cystine units present in an S-sulphonated form.
- the keratin-peptide includes a partially-hydrolyzed keratin.
- Exemplary keratin-peptides can be extracted from keratinaceous substrates,
- a suitable keratin-peptide is a keratin extracted from wool and sold under the trademark ProSinaTM,
- the keratin-peptide used in treatment compositions of the present invention interacts with keratin in the ' keratinaceous substrate upon application of the treatment composition. This interaction may be by, for example, formation of bonds between the keratin in the keratinaceous substrate and the keratin- peptide in the treatment composition, or physically coating the keratinaceous substrate.
- the term "bond" is to be interpreted in the broadest sense to include intermolecular interactions that cause association between the keratin in the keratinaceous substrate and the keratin-peptide in the treatment composition.
- the term bond includes van der Waal's interactions, as well as covalent, ionic, and hydrogen bonds
- the interaction between the keratin substrate and keratin-peptide may further result in cross-linking or other reinforcement of the keratinaceous substrate to provide physical and structural support and enhancement.
- the composition of the present invention may provide a physical coating of the keratin-peptide/dendrimer composition on the keratinaceous substrate.
- Dendrimer s are repetitively branched molecules. Typically, dendrimers are associated symmetrically about a core and can assume a three-dimensional structure.
- Dendrimers can be prepared from individual dendrimer units where a first dendrimer unit is attached to a core or base molecule and two (or more) second dendrimer units are attached to the first dendrimer unit, This process is repeated to add two dendrimer units to each of the second dendrimer units until the desired size and branching of the overall structure is achieved.
- the dendrimer component may contain hydrophobic groups.
- Such a structure is shown schematically in Figure 2 and includes a hydrophobic group 3 on the dendrimer unit.
- the groups Yi, Y 2 , and Ys are functional groups used to interact, associate or react with a complementary functional group on the keratin-peptide, with further dendrimer units to increase branching, or with additional hydrophobic groups.
- Yi, Y 2 , and Y3 can independently be OH, NH 2 , SH or COOK, as well as others.
- Yi, Y 2 , and Y3 can independently be, for example, OH, NH2, SH, CO OH, OR', NHR', SR'H, CO OR* or NR'2.
- the hydrophobic group R' can include, for example, a linear or branched C6-C20 carbon chain which can have additional functional groups present so long as the additional functional groups do not adversely affect the hydrophobic nature of the hydrophobic portion of the dendrimer unit.
- two hydrophobic groups 3 are . illustrated.
- the dendrimer may have no hydrophobic groups, one hydrophobic group, two hydrophobic groups or three or more hydrophobic groups, Further, the bond vertices illustrated in Figure 2 are not intended to be limited to C, but may also be N, S, O or any other suitable atom.
- the dendrimer unit may also contain other functional groups such as carboxyl groups and the like.
- Suitable dendrimers can be prepared through modification of existing dendrimer units by incorporating a hydrophobic unit to provide a hydrophobic portion to the molecule.
- a hydrophobic moiety can be attached to the dendrimer portion of a keratin- peptide/dendrimer composition after combining the dendrimer and the keratin-peptide,
- the hydrophobic portion may include, for example, a linear or branched C6-C20 carbon chain which can have additional functional groups present so long as the additional functional groups do not adversely affect the hydrophobic nature of the hydrophobic portion of the dendrimer unit.
- a number of smaller, less hydrophobic groups can be placed on one or more dendrimer units in order to provide a structure with hydrophobic portions and/or overall hydrophobicity in a part of the dendrimer or the dendrimer as a whole.
- the carbon chain can be derived from a fatty acid and attached to the dendrimer via formation of an ester or amide linkage.
- a suitably functionalized dendrimer unit can be reacted with a 1-alkene in an addition reaction.
- a 1-aikene can be epoxidized and reacted with a suitably functionalized dendrimer unit via a ring o ening reaction resulting in a 2 -hydroxy substituent on the hydrophobic portion of the dendrimer unit.
- a suitably functionalized dendrimer unit via a ring o ening reaction resulting in a 2 -hydroxy substituent on the hydrophobic portion of the dendrimer unit.
- the dendrimer unit can have the structure shown in Formula I, wherein R may be a functional group such as OH, NH 2 , SH or COOH.
- R may be a functional group such as OH, NH 2 , SH or COOH.
- An exemplary dendrimer is Polyamidoamine (PAMAM) dendrimer available from Dendritech, Inc. (Midland, MI, USA) having a structure shown in Formula I in which R-NH 2 .
- Suitable hydrophobic dendrimers may be prepared by reacting an "arm" of the dendrimer unit with one or more hydrophobic units. For example, if the dendrimer unit contains reactive hydroxyl group or amino group at the end of one or more "arms,” modification is accomplished by replacing one of the hydrogens of the pendent hydroxyl groups or amino groups with a suitable hydrophobic unit to provide a hydrophobic portion to the dendrimer unit.
- An exemplary structure resulting from such a modification prepared from a hydroxyl group is shown as Formula II.
- a hydrophobic dendrimer is prepared from dendrimer unit, for example a molecule as shown in Formula I, by reaction with a hydrophobic precursor epoxide, for example to form a structure as shown in Formula II below,
- the reaction product can include a mixture of compounds including the unreacted dendrimer unit, and dendrimer units having one, two, or three hydrophobic units attached.
- the reaction product contains about 50 mole % or less unreacted dendrimer unit, about 25% or less of dendrimer containing one hydrophobic unit, about 25% or less of dendrimer containing two hydrophobic units, and about 10 mole % or less of dendrimer containing three hydrophobic units,
- the product may contain approximately equal molar amounts of dendrimers containing one hydrophobic unit and dendrimers containing two hydrophobic units.
- the ratios and amounts of the various components in the reaction product can be controlled by adjusting the molar ratio of the dendrimer unit and hydrophobic precursor, as well as reaction conditions. Additionally, by controlling reaction conditions, it may be possible to prepare a dendrimer having two different hydrophobic groups, which could lead to a more complex mixture,
- the dendrimer unit may comprise reactive amino groups at the end of one or more "arms," and the dendrimer unit may be modified by reacting with one or - more hydrophobic chains at the amino end to form secondary or tertiary amine hydrophobic dendrimers.
- the suitable dendrimer may be a mixture of unreacted dendrimers, secondary amine containing hydrophobic dendrimer or tertiary amine containing hydrophobic dendrimer.
- Exemplary structures of a secondary amine containing branched hydrophobic dendrimer and a tertiary amine containing hydrophobic dendrimer are shown as Formulas III and IV, respectively,
- R may be a functional group that may or may not have reacted with additional hydrophobic units.
- R may be OH, NH 2 , SH, COOH, OR', NHR' ; SR'H, COOR' or NR' 2 , wherein R' is the hydrophobic unit.
- the hydrophobic group R' can include, for example, a linear or branched Ce-Cao carbon chain which can have additional functional groups present.
- compositions of the present invention are formed by mixing a keratin- peptide with a dendrimer.
- the resultant keratin-peptide/dendrimer compositions can exist in a variety of forms and combination of forms.
- functional groups of the two com onents may interact with one another. This - interaction may be, for example, chemical bonding or other associations of the functional groups.
- Chemical bonding may include covalent bonds, ionic bonds and hydrogen bonds, Association of the keratin-peptide and dendrimer can be through van der Waals interactions, dipole-dipole interactions, or other intermolecular interactions.
- a dendrimer may interact with one or more of keratin-peptide units and result in a keratin-peptide/dendrimer composition with a mixture of keratin-peptide/dendrimer complexes as explained below.
- Dendrimers may include a functional group that can react or associate with a complementary functional group on the keratin-peptide
- a "complementary functional group” is a moiety that can react or associate with a functional group on another molecule
- Examples of functional groups and complementary functional groups that may undergo association include, for example, carboxylic acids and alcohols (to form esters), carboxylic acids and amines (to form amides), amino groups (NH2) and leaving groups (e.g. tosylates, halides, mesylates, etc) to form secondary amines, hydroxyl groups and leaving groups (e.g. tosylates, halides, mesylates, etc) to form ethers, etc.
- Functional groups and complementary functional groups can also be polar groups (e.g., OH, SH, etc) or groups capable of ionization (e.g., NH 2 , COOH, etc.). In such embodiments association may occur by formation of ionic bonds, hydrogen bonds, and the like.
- polar groups e.g., OH, SH, etc
- groups capable of ionization e.g., NH 2 , COOH, etc.
- association may occur by formation of ionic bonds, hydrogen bonds, and the like.
- Persons skilled in the art will recognize that there are numerous functional group/complementary functional group combinations that can be used to couple dendrimer with keratin-peptide,
- the dendrimer interacts with the keratin-peptide in suc a way that the keratin-peptide constituent remains at least partially exposed for interaction or react with keratin of a keratinaceous substrate.
- the keratin- eptide/dendrimer composition is shown schematically in Figure 1 that includes a keratin-peptide constituent 1, in which X is a functional group on the keratin-peptide constituent, and a dendrimer portion 2, in which A and B represent sites available for interaction with additional keratin-peptide molecules, or for additional functionalization with a hydrophobic group.
- a and B can independently be OH, NH 2 , SH, COOH, OR', NHR', SR'H, COOR' or NR' 2j where R' is as defined above.
- Functional groups such as X on the keratin-peptide constituent 1 remain available for bonding with, associating with, coating, adhering to or attaching to keratin in the keratinaceous substrate,
- the dashed line in Figure 1 is intended to denote an interaction between the dendrimer portion 2 and keratin-peptide 1. This interaction may be through, for example, a van der Waal's interaction, dipole-dipole interactions ahydrogen bond, an ionic bond or a covalent bond.
- a preformed dendrimer may have a reactive functional group that can be coupled to the keratin-peptide. Coupling can ccur through a reactive functional group on the dendrimer and a complementary functional group of the keratin-peptide, The coupling of the keratin-peptide and the dendrimer may be through the mixing of the two, wherein the one or more of the functional groups on the dendrimer may associate with the keratin-peptide through interactions, such as van der Waal's interaction or hydrogen bonding.
- the preformed dendrimer can include or be reacted to include a group that interacts with and couples to a group on the keratin-peptide by forming a covalent bond.
- a group that interacts with and couples to a group on the keratin-peptide by forming a covalent bond.
- oppositely charged groups on the dendrimer and the keratin-peptide can form an ionic bond. Either of these schemes would similarly yield the structure shown schematically in Figure 1.
- one or more keratin-peptides may interact with the dendrimer without forming a chemical bond.
- the keratin restorative composition may comprise of a mixture of unreacted keratin-peptide, unreacted dendrimer, single keratin-peptide/dendrimer complexes, secondary keratin-peptide/dendrimer complexes, and/or tertiary keratin- peptide/dendrimer complexes,
- the term "complex" is to be interpreted to mean keratin-peptide and dendrimer that couple or associate to form a unit.
- Figure 1 is an example of a single keratin-peptide/dendrimer complex.
- a secondary keratin-peptide/dendrimer complex may be present when one dendrimer interacts with two keratin-peptides or two dendrimers interact with one keratin-peptide.
- a tertiary keratin-peptide/dendrimer complex may be present when a dendrimer interacts with three keratin-peptides or three dendrimers interact with one keratin-peptide.
- the keratin-peptide/dendrimer composition comprising a dendrimer constituent and a keratin-peptide constituent offers several advantages as a treatment composition,
- the keratin-peptide constituent remains available to react with keratin in the keratinaceous substrate, for example through a functional group such as X as shown in Figure 1 , to provide strengthening of the keratinaceous substrate similar to that achieved with the initial application of a hydrolyzed keratin,
- the keratiri- peptide/dendrimer composition in exemplary embodiments of the present invention also includes a dendrimer with a hydrophobic region.
- the dendrimer portion While the keratin-peptide constituent interacts or bonds with the nail keratin, the dendrimer portion is exposed to the environment, This can occur whether the keratin-peptide and dendrimer are mixed, associated, bonded, or chemically bonded, When this environment includes water, the dendrimer portion in essence forms a "shield" that prevents water from penetrating to the keratin-peptide constituent. Thus the keratin-peptide constituent is prevented from being solubilized by the water and the treatment composition remains intact for longer periods of time before additional treatment is required.
- the nail treatment remains intact for 2 or more days, 3 or more days, 4 or more days, 5 or more days, or 1 week or longer,
- the composition remains intact whether or not there is any additional coating placed on the nail over the nail treatment,
- the keratin-peptide/dendrimer may be present in the formulation from about 0.01 to about 15% by weight.
- keratin-peptide/dendrimer may be present in the formulation from about 0.1 to about 10% by weight, or from about 0, 1 to about 5% by weight
- the keratin-peptide and dendrimer may be present in a weight ratio from about 4:1 to about 1:60 based on the weight of keratin and dendrimer without solvent.
- keratin- eptide and dendrimer may be present in a weight ratio of about 2:1, about 1 : 1, about 1 :10, about 1 :26, about 1 :45, or about 1 : 52, In an embodiment, the keratin-peptide and dendrimer may be present in a weight ratio of about 2:1 or higher, about 1 :1 or higher, about 1 :10 or higher, about 1 :26 or higher, about 1 :45 or higher, or about 1:52 or higher.
- the keratin-peptide and dendrimer may be present in a weight ratio of about 2:1 or lower, about 1 :1 or lower, about 1:10 or lower, about 1 ;26 or lower, about 1 :45 or lower, or about 1 : 52 or lower,
- the amount of keratin-peptide can range from about 0.0002-12% by weight, about 0.008-12% by weight. About 0.001-1.5% by weight, or about 0.002-,0.25%, by weight.
- the keratin-peptide may be present in the formulation in an amount greater than about 0.0002 % by weight, greater than about 0,002 % by weight, greater than about 0,001% by weight, or greater than about 0.01% by weight.
- the keratin-peptide may be present in the formulation in an amount less than about 12% by weight, less than about 10% by weight, less than about 7,5% by weight, less than about 4% by weight, less than about 2.5% by weight, less than about 1% by weight, less than about 0.5% by weight, or less than about 0.25% by weight,
- the amount of dendrimer can range from about 0.0002-14.75% by weight, about 0,002-3% by weight, About 0.01-13.5% by weight, or about 0.01-14.75% by weight.
- the dendrimer may be present in the formulation in an amount greater than about 0,002 % by weight, greater than about0,02 % by weight, or greater than about 0.01% by weight.
- the dendrimer may be present in the formulation in an amount less than about 14,75% by weight, less than .about 10% by weight, less than about 7.5% by weight, less than about 4% by weight, less than about 2.5% by weight, or less than about 1% by weight.
- the present system allows the use of the keratin-peptide in an oil based carrier to penetrate, condition, and plasticize the nail, At the same time, the keratin-peptide/dendrimer composition binds to and seals the keratin substrate providing protection and improving resistance to common solvents such as acetone and water that are harmful to the structure of the keratin substrate, This reduces the severity of existing imperfections by providing additional bonding and protection as well as reducing the recovery time from those imperfections by arresting the propagation of cracks and weak spots between the cells in the keratin substrate,
- Treatment compositions of the invention may further include one or more solvents.
- Solvents can be present in an amount up to about 99% of the composition, for example at about 90% of the composition.
- solvents are non-polar or lipophilic solvents, including but not limited to ketones, alkyl acetates, alcohols, alkanes, alkenes, plant or nut oils and mixtures thereof.
- solvents include acetone, ethyl acetate, butyl acetate, isopropyl alcohol, ethanoL methyl ethyl ketone, toluene, hexane, sweet almond oil, jojoba oil, rice bran oil, vitamin E acetate and mixtures thereof.
- the solvent used depends, in part, on the use of the composition and can be readily determined by persons skilled in the art.
- Treatment compositions of the invention can include further additives such as an epoxy resin substantially composed of an ester fraction of an epoxidized esterified plant oil, or derivative thereof that provides adhesion when applied to a keratinaceous surface and cured, in such components the ester fraction includes one or more epoxidized fatty acid esters, or derivatives thereof, Each of the one or more fatty acid ester(s) is not a mono-, di- or triglyceride.
- the fatty acid ester(s), or derivative(s) thereof can be an alkyl ester, such as a methyl ester.
- the resin can include an ester fraction of one or more additional epoxidized esterified plant oils, or derivatives thereof.
- Treatment compositions of the invention can also include at least one polyhedral oligomeric silsesquioxane (POSS).
- PHS polyhedral oligomeric silsesquioxane
- Polyhedral oligomeric silsesquioxanes, as well as other components that can be used in compositions of the invention, are described in US Patent Application Publication No. 2014/0053859A1, which is incorporated herein by reference in its entirety.
- Treatment composition and formulations according to the present invention can be used in a variety of products, particularly cosmetic products.
- the compositions can be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied for cleansing, beautifying, promoting attractiveness, 'or altering appearance.
- Treatment composition and formulations of the invention are particularly suited for application to keratinaceous substrates, for example, skin, hair and nails
- Compositions containing a keratin-pep tide and dendrimer or keratin-peptide/dendrimer of the invention can be formulated into, for example, moisturizers, perfumes, lipsticks, eye and facial makeup preparations, cleansing shampoos, hair conditioners, permanent waves, hair colors, nail coatings, nail treatments and other cosmetic products or components of cosmetic products.
- treatment compositions according to the invention can include additional components satisfactory for use in these and other cosmetic compositions and products, so long as the additional components do not adversely affect the advantages of the present invention.
- the disclosed composition and formulation is a nail treatment or nail restorative composition for fingernails or toenails to prevent, treat, or ameliorate delamination, dryness, brittleness, cracking, chipping, splitting, texturing or other degradation of the nail material.
- the disclosed compositions and formulations are applied to the exposed fingernails or toenails to treat the nail material to prevent nail brittleness, delamination, dryness, cracking, chipping, texturing or other imperfections.
- the disclosed compositions and formulations are applied to the exposed fingernails or toenails to improve the appearance of the nail by binding together the structure and thus smoothing imperfections in the nail.
- Nail treatment compositions of the present invention may also serve as a decorative co ting by being incorporated into a nail enamel, varnish, or artificial nail system.
- the nail treatment composition may include a film forming polymer such as a cellulose ester.
- cellulose esters include nitrocellulose and cellulose acetate alkylates such as cellulose acetate propionate and cellulose acetate butyrate and the like,
- the nail treatment composition may also include a reactive (meth)acrylate that can be cured to form an acrylic coating.
- the term (meth)acrylate encompasses acrylates and/or methacrylates, including reactive monomers, and/or oligomers, and/or polymers.
- the (meth)acrylates may be selected from the group consisting of acrylic acid; methacrylic acid; alkyl acrylates and methacrylates, such as methyl methacrylate, ethyl methacrylate, propyl methacrylate, methyl acrylate, ethyl acrylate, propyl acrylate, etc; hydroxypropyl methacrylate (HPMA); hydroxyethyl methacrylate (HEMA, which may also serve as a solvent or co-solvent); THFMA; pyromellitic dianhydride
- the nail treatment composition may include other components used in nail coatings as known in the art.
- the nail treatment compositions of the present invention may further include a colorant.
- the colorant may be, for example a pigment or dye.
- the composition may comprise up to 10 wt % pigments and/or dyes.
- compositions may be applied to a nail using a medicine dropper or a brush.
- the compositions may be rubbed into the nail surface or may be left to penetrate or coat without mechanical assistance.
- the disclosed composition and formulation is a hair treatment or restorative composition for use on the hair to prevent, treat, or ameliorate dryness, brittleness, breaking or cracking or improve the texture or appearance of the. hair.
- the disclosed compositions and formulations are applied to the hair to prevent dryness, brittleness, breaking or cracking or to improve the texture or appearance of the hair.
- Compositions and formulations for application to hair include, but are not limited to, shampoos, conditioners, permanent waves, hair colors, hair sprays and hair treatments.
- Compositions and formulations of the invention can be applied to the hair by, for example, pouring, rubbing, spraying or brushing into the hair.
- Hair treatment or restorative composition and formulations of the invention can include other components used in hair products including, for example, colorants, fragrances, surfactants, emollients, emulsifiers, solvents, propellants, and the like.
- suitable components that are necessary or useful for the specific application,
- the disclosed composition and formulation is a skin treatment or restorative composition for use on the skin to prevent, treat, or ameliorate dryness, or cracking or to improve the texture or appearance of the skin
- the disclosed compositions and formulations are applied to the skin to prevent dryness or cracking, or to improve the texture or appearance of the skin.
- Compositions and formulations for application to skin include, but are not limited to moisturizers, perfumes, lipsticks, eye and facial makeup preparations, sprays and skin treatments, Compositions and formulations of the invention can be applied to the skin by, for example, pouring, rubbing, sprinkling, spraying or brushing onto the skin.
- Skin treatment or restorative composition and formulations of the invention can include other components used in skin products including, for example, colorants, fragrances, surfactants, emollients, emulsifiers, solvents, propellants, and the like. Persons skilled in the art will know of suitable components that are necessary or useful for the specific application.
- the keratin treatments may be incorporated into a wide range of products including nail treatments (such as base coats, top coats, and color treatments) including curable nail treatments, enamels, artificial nails and the like,
- the keratin treatment may also be incorporated into hair products, such as conditioners, moisturizers, shampoos, gels, mousse, etc.
- the lceratin treatment may also be incorporated into topical treatments such as lotions, moisturizers, skin creams and treatments, make-up, lipstick, etc.
- a hydrophobic dendrimer was prepared from Polyamidoaniine (P AMAM) and an e oxidized hydrophobic precursor in isopropanol, The reaction product was analyzed using High Performance Liquid Chromatography (HPLC) and Matrix Assisted Laser Desorption/Ionization - Time of Flight Mass Spectroscopy (MALDI-TOF), The MALDI-TOF data reflect a typical distribution that occurs during the hydrophobe reaction which uses epoxide chemistry, The presence of the parent mass peak, and the Na+ and K+ adducts commonly seen by this technique are reflected as "triplet" peaks.
- HPLC High Performance Liquid Chromatography
- MALDI-TOF Matrix Assisted Laser Desorption/Ionization - Time of Flight Mass Spectroscopy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16773991.1A EP3277249A4 (en) | 2015-04-03 | 2016-03-29 | Keratin treatments |
| AU2016243469A AU2016243469A1 (en) | 2015-04-03 | 2016-03-29 | Keratin treatments |
| RU2017133988A RU2017133988A (en) | 2015-04-03 | 2016-03-29 | KERATINOVA THERAPEUTIC AND PREVENTIVE REMEDIES |
| JP2018502609A JP2018510911A (en) | 2015-04-03 | 2016-03-29 | Keratin treatment |
| CN201680019673.9A CN107708651A (en) | 2015-04-03 | 2016-03-29 | Keratin processing |
| CA2981485A CA2981485A1 (en) | 2015-04-03 | 2016-03-29 | Keratin treatments |
| HK18104143.8A HK1244684A1 (en) | 2015-04-03 | 2016-03-29 | Keratin treatments |
| US15/721,988 US20210093538A9 (en) | 2015-04-03 | 2017-10-02 | Keratin Treatments |
| US17/129,072 US20210113447A1 (en) | 2015-04-03 | 2020-12-21 | Keratin treatments |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562142798P | 2015-04-03 | 2015-04-03 | |
| US62/142,798 | 2015-04-03 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/721,988 Continuation US20210093538A9 (en) | 2015-04-03 | 2017-10-02 | Keratin Treatments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016160796A1 true WO2016160796A1 (en) | 2016-10-06 |
Family
ID=57006363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2016/024698 Ceased WO2016160796A1 (en) | 2015-04-03 | 2016-03-29 | Keratin treatments |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3277249A4 (en) |
| JP (1) | JP2018510911A (en) |
| CN (1) | CN107708651A (en) |
| AU (1) | AU2016243469A1 (en) |
| CA (1) | CA2981485A1 (en) |
| HK (1) | HK1244684A1 (en) |
| RU (1) | RU2017133988A (en) |
| WO (1) | WO2016160796A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10004673B1 (en) | 2017-02-08 | 2018-06-26 | L'oreal | Hair treatment composition comprising Michael addition product and methods for treating hair |
| WO2019122738A1 (en) | 2017-12-22 | 2019-06-27 | Basf Beauty Care Solutions France Sas | Use of guerbet alcohol and/or caprylic/capric triglyceride as extraction solvent |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6068835A (en) * | 1996-06-28 | 2000-05-30 | Wella Aktiengesellschaft | Cosmetic compositions for hair treatment containing dendrimers or dendrimer conjugates |
| US6821509B2 (en) * | 2000-04-14 | 2004-11-23 | Cosmetica, Inc. | Nanoscopic hair care products |
| WO2005092275A1 (en) * | 2004-03-26 | 2005-10-06 | L'oreal | Cosmetic composition comprising a dendritic polymer with peripheral fatty chains, a surfactant and a cosmetic agent, and uses thereof |
| US20080247980A1 (en) * | 2004-08-17 | 2008-10-09 | Hakan Claes Bjornberg | Hair Care Compositions Comprising a Dendritic Polymer |
| US7862805B2 (en) * | 2001-06-07 | 2011-01-04 | L'oreal | Cosmetic composition forming after application a supramolecular polymer |
| US20150056154A1 (en) * | 2012-03-26 | 2015-02-26 | Otc Gmbh | Hair conditioning composition for permanent and semi-permanent hair coloration applications |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527524A (en) * | 1986-08-18 | 1996-06-18 | The Dow Chemical Company | Dense star polymer conjugates |
| JPH04308515A (en) * | 1991-04-03 | 1992-10-30 | Seiwa Kasei:Kk | Cosmetic composition |
| US6013250A (en) * | 1995-06-28 | 2000-01-11 | L'oreal S. A. | Composition for treating hair against chemical and photo damage |
| FR2783418B1 (en) * | 1998-09-17 | 2000-11-10 | Oreal | ANTI-WRINKLE COMPOSITION COMPRISING A COMBINATION OF TENSIONING POLYMERS OF SYNTHETIC AND / OR NATURAL ORIGIN AND DENDRITIC POLYESTERS |
| EP2077139A1 (en) * | 2008-01-02 | 2009-07-08 | International Lacquers S.A. | Anhydrous cosmetic composition |
| WO2010102891A2 (en) * | 2009-03-10 | 2010-09-16 | Unilever Plc | Composition |
| US8663667B2 (en) * | 2009-06-29 | 2014-03-04 | L'oreal | Refreshing cream foundation in gel form |
| AU2012275516A1 (en) * | 2011-06-28 | 2014-01-23 | University Of Utah Research Foundation | Adhesive complex coacervates and methods of making and using thereof |
| CN104127327B (en) * | 2014-06-25 | 2015-10-28 | 佛山市安安美容保健品有限公司 | A kind of hair products containing marine protein peptide |
-
2016
- 2016-03-29 CN CN201680019673.9A patent/CN107708651A/en active Pending
- 2016-03-29 WO PCT/US2016/024698 patent/WO2016160796A1/en not_active Ceased
- 2016-03-29 JP JP2018502609A patent/JP2018510911A/en active Pending
- 2016-03-29 RU RU2017133988A patent/RU2017133988A/en not_active Application Discontinuation
- 2016-03-29 EP EP16773991.1A patent/EP3277249A4/en not_active Withdrawn
- 2016-03-29 CA CA2981485A patent/CA2981485A1/en active Pending
- 2016-03-29 AU AU2016243469A patent/AU2016243469A1/en not_active Abandoned
- 2016-03-29 HK HK18104143.8A patent/HK1244684A1/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6068835A (en) * | 1996-06-28 | 2000-05-30 | Wella Aktiengesellschaft | Cosmetic compositions for hair treatment containing dendrimers or dendrimer conjugates |
| US6821509B2 (en) * | 2000-04-14 | 2004-11-23 | Cosmetica, Inc. | Nanoscopic hair care products |
| US7862805B2 (en) * | 2001-06-07 | 2011-01-04 | L'oreal | Cosmetic composition forming after application a supramolecular polymer |
| WO2005092275A1 (en) * | 2004-03-26 | 2005-10-06 | L'oreal | Cosmetic composition comprising a dendritic polymer with peripheral fatty chains, a surfactant and a cosmetic agent, and uses thereof |
| US20080247980A1 (en) * | 2004-08-17 | 2008-10-09 | Hakan Claes Bjornberg | Hair Care Compositions Comprising a Dendritic Polymer |
| US20150056154A1 (en) * | 2012-03-26 | 2015-02-26 | Otc Gmbh | Hair conditioning composition for permanent and semi-permanent hair coloration applications |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE Pubchem 13 September 2005 (2005-09-13), Database accession no. 276 * |
| See also references of EP3277249A4 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10004673B1 (en) | 2017-02-08 | 2018-06-26 | L'oreal | Hair treatment composition comprising Michael addition product and methods for treating hair |
| WO2019122738A1 (en) | 2017-12-22 | 2019-06-27 | Basf Beauty Care Solutions France Sas | Use of guerbet alcohol and/or caprylic/capric triglyceride as extraction solvent |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018510911A (en) | 2018-04-19 |
| EP3277249A4 (en) | 2018-12-19 |
| RU2017133988A (en) | 2019-05-06 |
| HK1244684A1 (en) | 2018-08-17 |
| EP3277249A1 (en) | 2018-02-07 |
| CA2981485A1 (en) | 2016-10-06 |
| RU2017133988A3 (en) | 2019-09-12 |
| AU2016243469A1 (en) | 2017-10-26 |
| CN107708651A (en) | 2018-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010266495B2 (en) | Non-petrochemically derived cationic emulsifiers that are neutralized amino acid esters and related compositions and methods | |
| KR102043855B1 (en) | Functional composition for surface modification | |
| EP3139901B1 (en) | Non-petrochemically derived cationic emulsifiers and related compositions and methods | |
| JP2011502171A (en) | Keratin derivative and method for producing the same | |
| FR2718637A1 (en) | Cosmetic composition to be applied to the nail. | |
| US20140328784A1 (en) | Hair Conditioning Cosmetic Compositions Containing A Mixture Of Amidoamines | |
| TW201632171A (en) | Oil-in-water-type emulsion composition | |
| EP2682096B1 (en) | Cosmetic base material, and cosmetic containing said cosmetic base material | |
| KR20170099656A (en) | Cosmetic compositions for moisturizing | |
| WO2016160796A1 (en) | Keratin treatments | |
| US20210113447A1 (en) | Keratin treatments | |
| JP7842026B2 (en) | Composition containing hydrolyzed protein | |
| US20210228462A1 (en) | Composition for dyeing | |
| JP2009161519A (en) | Cosmetic base and hair cosmetic | |
| US20150306016A1 (en) | Pearlescent hair care composition | |
| JP7281172B2 (en) | cosmetics | |
| AU2024201086B2 (en) | Improved compositions and methods for styling hair fibers | |
| JP3851324B2 (en) | Dithiol and its use for hair strengthening | |
| JP7169623B2 (en) | Cosmetic containing arginine ester | |
| WO2023228911A1 (en) | Novel agent for improving resilience and/or body of hair | |
| KR20190126033A (en) | Functional composition for surface modification | |
| JP2013087075A (en) | Cosmetic | |
| FR2745176A1 (en) | Cosmetic composition for skin and hair care | |
| JP2014224054A (en) | Hair cosmetic | |
| JPH0571564B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16773991 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2981485 Country of ref document: CA Ref document number: 2018502609 Country of ref document: JP Kind code of ref document: A |
|
| REEP | Request for entry into the european phase |
Ref document number: 2016773991 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2016243469 Country of ref document: AU Date of ref document: 20160329 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2017133988 Country of ref document: RU |





